510(k) Report

510(k) · Cleared

Cleared

Medical Treatment Chair, T400, T500,T600

K091727510(k) TraditionalCleared Jul 6, 200925-day reviewClass II21 CFR 890.3110

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Fresenius Medical Care South Asia Pacific Pty, Ltd. · INO Chair, Positioning, Electric

Cleared on Jul 6, 2009 after a 25-day review. The FDA summary names its predicate without a number.

Decided
Jul 6, 2009
Review
25 days
Class
Class II
Product code
INO
Recalls
None
Predicates
0

The FDA summary names its predicate without a number.

FIG. 1 — Lineage of K091727Source: FDA 510(k) database · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in INO? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—Convertible© I-Series Positioning and Transfer Chair
Named without a submission number
—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All INO devices

INO Chair, Positioning, Electric: FDA decisions, review times, recalls and adverse event reports over 20 years. 2009, this device’s year, is highlighted.

FDA decisions per year · INO

1in 2014

2007: 22008: 22009: 42010: 12011: 12013: 12014: 1
2007high 4 (2009) · low 0 (2012)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · INO

126in 2009

2009: 126 days median
2007high 126 (2009)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · INO

1in 2022

2022: 1
2007high 1 (2022) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · INO

29in 2025

2007: 12008: 52009: 62010: 72011: 202012: 152013: 242014: 162015: 232016: 352017: 382018: 382019: 372020: 412021: 492022: 292023: 292024: 202025: 29
2007high 49 (2021) · low 1 (2007)2025

MAUDE reports naming product code INO, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—01
20082—05
2009412606
20101—07
20111—020
20120—015
20131—024
20141—016
20150—023
20160—035
20170—038
20180—038
20190—037
20200—041
20210—049
20220—129
20230—029
20240—020
20250—029
20260—0—

What is it indicated for?

The Medical Treatment Chairs are intended for use in medical procedures such as the administration of renal dialysis to, and taking blood from, patients in hospital departments or home use. under the supervision of trained medical staff. The Medical Treatment Chairs are also intended for use In day surgery and nursing homes. The chairs are designed so that the occupant is accommodated In a seated position with the hips moved back so that the occupant's…

Read the full statement (186 words)

The Medical Treatment Chairs are intended for use in medical procedures such as the administration of renal dialysis to, and taking blood from, patients in hospital departments or home use. under the supervision of trained medical staff. The Medical Treatment Chairs are also intended for use In day surgery and nursing homes. The chairs are designed so that the occupant is accommodated In a seated position with the hips moved back so that the occupant's back is against the back rest and the legs outstretched and supported by the seat and leg rests.

The chairs are also used to position patients for easy access by healthcare professionals. The chairs are designed so that the occupant is accommodated in a seated position with the hips moved back so that the occupant's back is against the back rest and the legs outstretched and supported by the seat and leg rests.

All models are intended to be used by patients with a weight not exceeding:

- 130kg (T100 and T200 series)

- 130kg (T300 and T400 series)

- 200kg (T500, T550, T600 and T650 series)

- 300kg (T500B, T600B)

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K091727: Medical Treatment Chair, T400, T500,T600.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K091727

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Page last updated Nov 3, 2026